| ²é¿´: 1807 | »Ø¸´: 2 | |||
| ±¾Ìû²úÉú 1 ¸ö ·ÒëEPI £¬µã»÷ÕâÀï½øÐв鿴 | |||
scswpiyly½ð³æ (СÓÐÃûÆø)
|
[ÇóÖú]
Çë°ïæ·ÒëÒ»¶Î¹ØÓÚÉúÎïÒ½Ò©·½ÃæµÄÓ¢ÎÄ£¬Ð»Ð»~
|
||
|
FIG. 11 shows inhibitory activities of the wheat bran extract against the expression of the transcription factor NF-¦ÊB for cytokines. EXPERIMENTAL EXAMPLE 1-3:Assay for Inhibitory Activity against Production of Cytokine ¨C RT-PCR EXPERIMENTAL EXAMPLE 1-4-1: Inhibitory Activity against NF-¦ÊB Expression- Luciferase Assay FIG. 14 shows inhibitory activities of isolates from the wheat bran extract against the production of cytokines. As used herein, the term ¡°allergic diseases¡± means clinical symptoms that are caused by allergic reactions induced upon the activation of mast cells, such as the degranulation of mast cells. Prostaglandins promote the migration of leukocytes to inflammation sites while the inflammatory cytokines induce the expression of iNOS, which catalyzes the production of NO, causative of cytotoxicity and various inflammatory reactions, and the expression of COX-2, responsible for inflammation and pain. |
» ²ÂÄãϲ»¶
Çà»ùÈçºÎÆÆ¾Ö
ÒѾÓÐ7È˻ظ´
ÓжàÉÙÈËÊǽñÌì²éϵͳ֪µÀ½á¹ûµÄ£¿
ÒѾÓÐ17È˻ظ´
»ù½ð²»ÖУ¬¹²Ãã
ÒѾÓÐ10È˻ظ´
¹ú×ÔÈ»ÃæÉϸ´ÅÌ~»¶ÓÌÖÂÛ
ÒѾÓÐ11È˻ظ´
Ϊʲô×ÊÖúÊý¸÷´ó¸ßУ¶¼´´Ð¸ߣ¬×Ô¼ºÉêÇëÔõô¾ÍÕâôÄÑ
ÒѾÓÐ7È˻ظ´
»ù½ðδÖУ¬ÕâÖÖ´ð¸´ÊÇÄ£°åÂð£¿
ÒѾÓÐ6È˻ظ´
¿´°åÉÏÕâô¶àÖеģ¬ÓеãÏñ50ÈËȺÀï49¸öÈ˶¼ÊÇÆ×ÓµÄÄÇÖָоõ¡¡
ÒѾÓÐ6È˻ظ´
µ¼Ê¦Í²ۣºÎÒÔõô̯ÉÏÁËÕâô¸ö¼«Æ·Ñо¿Éú£¡
ÒѾÓÐ6È˻ظ´
Ôõô¿´Çà»ùÖÐÁËûÓа¡
ÒѾÓÐ5È˻ظ´
ÃÎÏë
ÒѾÓÐ3È˻ظ´
¹Å¿É¤×
ÈÙÓþ°æÖ÷ (ÎÄ̳¾«Ó¢)
- ·ÒëEPI: 323
- Ó¦Öú: 91 (³õÖÐÉú)
- ¹ó±ö: 16.835
- ½ð±Ò: 19133.1
- É¢½ð: 40372
- ºì»¨: 275
- ɳ·¢: 183
- Ìû×Ó: 25427
- ÔÚÏß: 1083.6Сʱ
- ³æºÅ: 1034379
- ×¢²á: 2010-06-02
- ÐÔ±ð: GG
- רҵ: Ò©ÎïÉè¼ÆÓëÒ©ÎïÐÅÏ¢
- ¹ÜϽ: µ¼Ê¦ÕÐÉú
¡¾´ð°¸¡¿Ó¦Öú»ØÌû
|
ͼ11ÏÔʾ£¬ÂóôïÌáÈ¡Îï¶Ôϸ°û¼¤ËØ×ªÂ¼Òò×ÓNF-¦ÊBµÄ±í´ïÓÐÒÖÖÆ×÷ÓᣠʵÑé1-3£º·ÖÎö¶Ôϸ°û¼¤ËØ-Äæ×ªÂ¼¾ÛºÏøÁ´·´Ó¦²úÎïµÄÒÖÖÆ×÷Óà ʵÑé1-4£ºNF-¦ÊB±í´ï-Ó©¹âËØÃ¸ÊÔÑéµÄÒÖÖÆ×÷Óà ͼ14ÏÔʾ£¬ÂóôïÌáÈ¡ÎïµÄ·ÖÀëÎï¶Ôϸ°û¼¤ËزúÎïµÄÒÖÖÆ×÷Óà ÕýÈç±¾ÎÄÔø¾ËùÓã¬ÊõÓï"±äÓ¦ÐÔ¼²²¡"µÄÒâ˼ÊÇÔÚ·Ê´óϸ°û»î»¯×÷ÓÃÓÕµ¼µÄ¹ýÃô·´Ó¦¶øÒýÆðµÄÁÙ´²Ö¢×´£¬±ÈÈç·Ê´óϸ°ûÍÑ¿ÅÁ£¡£µ±Ñ×ÐÔÒò×ÓÓÕµ¼iNOS±í´ïʱ£¬Ç°ÁÐÏÙËØ´Ùʹ°×ϸ°ûÒÆ¶¯µ½Ñ×֢λµã£¬´ÙʹNOµÄ²úÉú£¬¶øÒýÆðϸ°û¶¾ÐԺ͸÷ÖÖÑ×Ö¢·´Ó¦ÒÔ¼°COX-2µÄ±í´ï£¬´Ó¶ø²úÉúÑ×Ö¢ºÍÌÛÍ´¡£ |

2Â¥2012-06-15 15:31:26
8814402
ÖÁ×ðľ³æ (Ö°Òµ×÷¼Ò)
- ·ÒëEPI: 509
- Ó¦Öú: 18 (СѧÉú)
- ¹ó±ö: 0.381
- ½ð±Ò: 12921.1
- É¢½ð: 47
- ºì»¨: 16
- Ìû×Ó: 4185
- ÔÚÏß: 357.9Сʱ
- ³æºÅ: 1184404
- ×¢²á: 2011-01-06
- רҵ: Ò©ÎïѧÆäËû¿ÆÑ§ÎÊÌâ
¡¾´ð°¸¡¿Ó¦Öú»ØÌû
¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï
scswpiyly: ½ð±Ò+20, ·ÒëEPI+1, ¡ï¡ï¡ï¡ï¡ï×î¼Ñ´ð°¸, thanks£¡ 2012-06-15 16:55:28
scswpiyly: ½ð±Ò+20, ·ÒëEPI+1, ¡ï¡ï¡ï¡ï¡ï×î¼Ñ´ð°¸, thanks£¡ 2012-06-15 16:55:28
|
FIG. 11 shows inhibitory activities of the wheat bran extract against the expression of the transcription factor NF-¦ÊB for cytokines.ͼ11 ÂóôïÌáÈ¡Îï¶Ôϸ°ûÒò×ÓµÄת¼Òò×ÓNF-kB±í´ïµÄÒÖÖÆ»îÐÔ EXPERIMENTAL EXAMPLE 1-3:Assay for Inhibitory Activity against Production of Cytokine ¨C RT-PCRÊÔÑéÀý1-3 ϸ°ûÒò×ÓÉú³ÉÒÖÖÆ»îÐÔµÄRT-PCR²â¶¨ EXPERIMENTAL EXAMPLE 1-4-1: Inhibitory Activity against NF-¦ÊB Expression- Luciferase AssayÊÔÑéÀý1-4-1£ºÓ«¹âËØÃ¸·¨²â¶¨NF-kB±í´ïÒÖÖÆ»îÐÔ FIG. 14 shows inhibitory activities of isolates from the wheat bran extract against the production of cytokines.ͼ14 ÂóôïÌáÈ¡Îï·ÖÀëµ¥Ìå¶Ôϸ°ûÒò×ÓÉú³ÉµÄÒÖÖÆ»îÐÔ As used herein, the term ¡°allergic diseases¡± means clinical symptoms that are caused by allergic reactions induced upon the activation of mast cells, such as the degranulation of mast cells. ÔÚÕâÀÊõÓï¡°±äÓ¦ÐÔ¼²²¡¡±ÊÇÖ¸ÓÉÖîÈç·Ê´óϸ°ûÍÑ¿ÅÁ£µÈ·Ê´óϸ°û»î»¯ËùÓÕ·¢µÄ±äÓ¦ÐÔ·´Ó¦ËùÖµÄÁÙ´²Ö¢×´¡£Prostaglandins promote the migration of leukocytes to inflammation sites while the inflammatory cytokines induce the expression of iNOS, which catalyzes the production of NO, causative of cytotoxicity and various inflammatory reactions, and the expression of COX-2, responsible for inflammation and pain. ǰÁÐÏÙËØ´Ù½ø°×ϸ°ûÏòÑ×Ö¢²¿Î»Ç¨ÒÆ£¬¶øÑ×֢ϸ°ûÒò×ÓÓÕµ¼ÓÕµ¼ÐÔÒ»Ñõ»¯µªºÏøµÄ±í´ï£¬ºóÕß´ß»¯NOµÄÉú³É£¬ÊÇϸ°û¶¾ÐԺ͸÷ÖÖÑ×Ö¢·´Ó¦µÄÔÒò£»iNOS»¹´ß»¯ÓëÑ×Ö¢ºÍÌÛÍ´Ïà¹ØµÄ»·Ñõ»¯Ã¸2µÄ±í´ï¡£ |
3Â¥2012-06-15 15:37:38









»Ø¸´´ËÂ¥
ͶƱ: